Jefferies Group’s Aceragen Inc ACGN Stock Holding History

Jefferies Group’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,944	Closed	-$65K	–	2094
2021 Q1	$65K	Buy	+2,944	New	+$221K	﹤0.01%	1480

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Jefferies Group's ACGN Position: Q2 2021 in Review

Jefferies Group sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 135 shares — an estimated $2.98K sold.

Jefferies Group first reported a position in ACGN in Q4 2018 and held it in 2 quarters. The position peaked at $43K in Q4 2018. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

Jefferies Group reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
Jefferies Group sold 135 Aceragen Inc shares in Q2 2021, an estimated $2.98K.
Jefferies Group first reported a position in Aceragen Inc in Q4 2018 and held it in 2 quarters.
Jefferies Group's Aceragen Inc position peaked at $43K in Q4 2018.
47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.